Ambien Class Action Suit May Serve As Wake-Up Call For Competitors
Executive Summary
A civil class action lawsuit in Manhattan federal court alleging that Sanofi-Aventis failed to adequately warn patients of the risk of sleep walking and sleep eating with Ambien (zolpidem) could open the door for other agents in the highly competitive sleep category
You may also be interested in...
Sleep Agents Update Warnings As FDA Seeks Further Study Of “Complex” AEs
Questions about the safety of drugs in the sedative-hypnotic class could warrant additional clinical trials to further evaluate the complex sleep-related behaviors associated with the drugs, FDA said in announcing stronger warnings for the class March 14
Sleep Agents Update Warnings As FDA Seeks Further Study Of “Complex” AEs
Questions about the safety of drugs in the sedative-hypnotic class could warrant additional clinical trials to further evaluate the complex sleep-related behaviors associated with the drugs, FDA said in announcing stronger warnings for the class March 14
Benzodiazepines, OTCs Are As Effective As Newer Rx Sleep Agents - Article
Newer insomnia treatments are no more effective than benzodiazepines and OTC antihistamines, Consumer Reports' August 2006 "Best Buy Drugs" report says